• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Sigyn Therapeutics Inc (OP:SIGY)

    2.760 -0.990 (-26.40%)
    Streaming Delayed Price Updated: 3:51 PM EDT, Oct 3, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Sigyn Therapeutics Inc

    < Previous 1 2 3 Next >
    Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    Sigyn Therapeutics to Present at the Life Sciences Virtual Investor Forum on September 18th
    Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    Sigyn Therapeutics Announces Cardiovascular Disease Study
    Via TheNewswire.com
    Topics Death
    Sigyn Therapeutics to Present at Tomorrow's Emerging Growth Conference
    The Company Invites Investors, Industry Executives, and Analysts to Attend Its Real-time, Interactive Presentation 
    Via TheNewswire.com
    Life Science Virtual Investor Forum Agenda Announced for September 18th
    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    Sigyn Therapeutics Appoints Dr. Christoph Zaba to Its Scientific Advisory Board
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Sigyn Therapeutics Appoints Dr. Christoph Zaba to Its Scientific Advisory Board
    Via TheNewswire.com
    Sigyn Therapeutics Announces Cardiovascular Disease Study
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Death
    RETRANSMISSION: Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc.
    Via ACCESS Newswire
    Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc.
    Via ACCESS Newswire
    Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Death
    Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making
    SAN DIEGO, CA - March 12, 2025 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY) today released the following note authored by its CEO, Jim Joyce. 
    Via TheNewswire.com
    Topics Death
    Sigyn CEO Note: Combating the Rising Threat of New Pandemic Viruses
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Sigyn CEO Note: Combating the Rising Threat of New Pandemic Viruses
    SAN DIEGO, CA - March 5, 2025 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), today released the following note authored by its Chairman and CEO, Jim Joyce. 
    Via TheNewswire.com
    Sigyn Therapeutics to be Featured in Fireside Chat With Zacks Healthcare Analyst
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Sigyn Therapeutics to be Featured in Fireside Chat With Zacks Healthcare Analyst
    The Exclusive Event Kicks-Off Tomorrow February 26th at 4pm Eastern 
    Via TheNewswire.com
    Sigyn Therapeutics to Present at Tomorrow's Emerging Growth Conference
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing
    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    Sigyn Therapeutics to Present at Tomorrow’s Small Cap Growth Virtual Investor Conference
    Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    Small Cap Growth Virtual Investor Conference Agenda Announced for February 6th
    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    Sigyn Therapeutics Announces the Appointment of Michael Ryan to Its Board of Directors
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Sigyn Therapeutics Announces the Appointment of Michael Ryan to Its Board of Directors
    SAN DIEGO, CA - January 29, 2025 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a developer of blood purification technologies to treat life-threatening conditions,... 
    Via TheNewswire.com
    OTCQB Venture Virtual Investor Conference Presentations Now Available for On-Demand Viewing
    Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    BioMedNewsBreaks — Sigyn Therapeutics Inc. (SIGY) Announces Q1 2024 Financial Results
    Via Investor Brand Network
    Topics Death
    Sigyn Therapeutics Reports First Quarter 2024 Financial Results
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Sigyn Therapeutics Reports First Quarter 2024 Financial Results
    SAN DIEGO, CA - (NewMediaWire) - May 15, 2024 - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today announced financial results for... 
    Via TheNewswire.com
    BioMedNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Announces Publication of Article on Emerging Candidate – Sigyn Therapy(TM)
    Via Investor Brand Network
    Topics Death
    Sigyn Therapeutics Discloses Publication of "Sigyn Therapy, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections"
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    BioMedNewsBreaks — Sigyn Therapeutics Inc. (SIGY) Leveraging Portfolio to Overcome Current Limitations in Healthcare
    Via Investor Brand Network
    Topics Death
    Sigyn Therapeutics Inc. (SIGY) CEO Discusses Company’s Blood Purification Therapies to Address Cancer and Other Life-Threatening Conditions at the Emerging Growth Conference
    Via Investor Brand Network
    < Previous 1 2 3 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.